Replies to post #310205 on Anavex Life Sciences Corp (AVXL)

[boi568]

The Q and A related to the post-OLE patient level, so I don't think his answer is problematic.

[Investor2014]

Yes Anavex supplies the drug, but presumably not in practise patient by patients, pill by pill. Therefore the company will not have an accurate up to date account of just how many patients are actively taking A2-73 under SAS Cat B.

Anavex at the outset August 2020 will have approved SAS Cat B supply to whatever number of prescribing physicians are involved with the <= 21 P2a AD patients that were eligible. Now 10 months later how would Missling know the exact number of patients still on the drug.

But what do I know, I am not a doc.